Event 04.25

💭 Looking back at hashtag#NATA25 at the Science Congress Center in Munich! To celebrate its 25th anniversary, NATA brought together experts and practitioners from around the world to discuss the major challenges in transfusion medicine. This year, the debates focused in part on Patient Blood Management (PBM), a true public health challenge. A must-attend event that drives innovation and advances clinical practices. And we are proud that i-SEP was part of it. A few highlights: 👉 Dr. Bertrand Rozec (CHU de Nantes) spoke during the session “Cell Salvage: The Past, Present and Game-Changing Future”, highlighting emerging technologies in the operating room, including our same™ solution. 👉 On friday morning, our joint symposium with HemoSonics shed light on blood management in cardiac surgery and obstetric: from coagulation monitoring with Quantra® and qLabs® FIB to comprehensive autotransfusion (platelets + red blood cells) thanks to same™. We had the pleasure of hearing inspiring talks from Aryeh Shander, Anne-Sophie Ducloy-Bouthors and Dr. med. Gösta Lotz, DESA, MA. 👉 Finally, our booth became a real hub for exchange, where we showcased our same™ technology. 💡 Why same™? Our solution addresses a major public health issue. By enabling hemorrhagic patients to recover both their red blood cells and their own platelets, i-SEP provides an impactful solution that offers significant patient benefits and cost savings for healthcare systems. In the context of strained blood management, this is an innovative solution that represents a major step forward in transfusion strategy. 📆 Next stop: Lisbon Join us at the European Society of Anaesthesiology and Intensive Care Congress, from May 25-27, 2025!

Read more
Event 04.25

📍 Live from #NATA25 in Munich! This morning, we had the pleasure of co-hosting a symposium with our partner HemoSonics, focusing on cardiac surgery and obstetrics, and exploring innovative approaches in coagulation monitoring and autotransfusion. 🕘 9:00 – 10:00 AM 📍 Audimax – Plenary Room Topic: “Patient Blood Management in cardiac surgery and obstetrics: from coagulation monitoring with Quantra® & qLabs® FIB to comprehensive autotransfusion (platelets + red blood cells) with same™” A big thank you to our speakers for their insightful presentations: ➡️ Aryeh Shander : “Introduction and Current State of PBM” ➡️ Anne-Sophie Ducloy-Bouthors : “Coagulation monitoring in obstetrics with Quantra® and qLabs® FIB” ➡️ Dr. med. Gösta Lotz, DESA, MA : “Initial feedback on same™ in Frankfurt: comprehensive autotransfusion (Platelets + RBC)” Our same™ technology is redefining transfusion strategies by enabling patients to recover their own red blood cells and platelets, significantly reducing the need for donor blood. 👋 Visit Guillaume Laurent and Georges Tabary at booth 1-02 to discover our solution and connect with us.

Read more
Event 04.25

📌 We were present at the J.E.P.U. Anesthesia & Intensive Care Congress with Stago BioCare! Each year, this congress brings together over 3,000 anesthesiologists and nurse anesthetists for two days of discussions on the latest advancements in the field, with around one hundred speakers and fifty exhibitors. A big thank you to everyone who stopped by to learn more about our same™ technology. 🩸 Our solution addresses a major public health issue. By enabling patients to recover their own red blood cells and platelets during hemorrhagic surgeries, i-SEP delivers significant benefits to patients while also generating cost savings for our healthcare system. In a context of increasing pressure on blood resources, this is an innovative solution that represents a major step forward in transfusion strategy. 📆 Save the date: Join us on April 24, 25, and 26 in Munich for the NATA congress.

Read more
Event 01.25

Celebrating Our First Participation at The Society of Thoracic Surgeons hashtag#STS2025 in Los Angeles As the Society of Thoracic Surgeons (STS) Annual Meeting in Los Angeles comes to a close today, we are proud to have showcased our system for the very first time in the United States. This marks a significant milestone in our journey to contribute to innovation in the cardiothoracic field. In the face of increasing pressure on blood reserves, i-SEP presents a major innovation for patients and healthcare professionals : sam™ system*, which is revolutionizing platelet and red blood cell (RBC) autotransfusion in cardiac surgery. 🙏We want to thank everyone who visited our booth, engaged in discussions, and shared valuable insights. Your support and enthusiasm mean the world to us. Our thoughts remain with those affected by the recent wildfires in the region. The resilience of this community is truly inspiring. This is just the beginning of our adventure, and we look forward to what’s ahead as we continue to grow and collaborate with this amazing community.

Read more
News 12.24

✨ i-SEP team wishes you Happy Holidays and brightest wishes for a Happy New Year! We would also like to thank all our partners, as well as the medical establishments using same™, for their trust and for this successful year. See you in 2025! 📆

Read more
Event 12.24

i-SEP innovates to combat blood shortages – Present at the CHU x HealthTech Connexion Day , the Nantes MedTech i-SEP presented its latest innovation: an intraoperative auto-transfusion system. Objective? To offer an alternative to blood transfusions from banks during surgical procedures and thus, overcome increasingly frequent shortages.

Read more
Event 12.24

🚀 We attended the CHU HealthTech Connexion Day #3 at the Grand Palais in Lille! For the past three years, this annual event, organized by the France Biotech association in partnership with the Conference of CHRU General Directors, has been fostering collaborations between university hospitals (CHUs) and HealthTech entrepreneurs. This year, 1,080 participants joined this edition, rich in exchanges and innovations. Highlights of the day: 👉 Guillaume Laurent, i-SEP’s Commercial & Marketing Director, spoke during the workshop “From innovative purchasing processes to tailor-made hospital systems: what continuum fosters breakthrough innovation?” This engaging session explored the challenges and drivers of innovation in the healthcare sector alongside Julien Moiroux, Camille Gladieux, Denies Fanette, Benoit DERVAUX, Eric Ermenault, Louis Potel, and Vincent Vercamer. 👉 We also gave an exclusive interview to ON HEALTH, a media platform dedicated to health innovation. Stay tuned to discover our contribution! 📲 A big thank you to everyone who stopped by to learn more about our same™ technology! Our solution addresses a critical public health challenge. By enabling hemorrhagic patients to recover their own red blood cells and platelets, i-SEP provides a significant patient benefit while reducing costs for the healthcare system. In the context of blood supply constraints, this innovative solution represents a major breakthrough in transfusion strategy. 📆 Save the date: Join us on January 24, 25, and 26, 2025, in Los Angeles for the Society of Thoracic Surgeons Conference!

Read more
News 11.24

🚀 An important step in deploying our solution across Europe: our first publication introduces a predictive model assessing the budgetary and organizational impact (OBIM) of gradually replacing intraoperative autotransfusion systems in French hospitals. Developed in partnership with RWEALITY and the pharmacy team at the Georges Pompidou European Hospital in Paris, this model anticipates the shift from traditional cell centrifugation, which only preserves red blood cells, to our innovative same™ device. Using tangential filtration, same™ recovers and cleanses the patient’s blood, preserving both platelets and red blood cells, leading to significant cost and efficiency benefits. 🩸In a study of 600 cardiothoracic surgery patients, using same™ resulted in a 45% reduction in red blood cell transfusions. Platelet use decreased by 60% for moderate bleeding and by 90% for severe bleeding, yielding annual savings of €44,601 from the first year, with cumulative savings of €535,206 over five years as the device’s market share grows to 100%. This model offers hospitals a clear, precise view of the expected medico-economic benefits. By quantifying the cost savings and efficiency gains, it supports decision-making for healthcare centers looking to optimize both patient outcomes and resource management.

Read more
News 10.24

🩸Cutting-Edge Innovation : How same™ is redefining blood transfusion 🔊 During our recent interview on Télénantes, we shared an update on the rollout of our same™ technology across Europe. Based in Nantes, we are proud to see how our innovation in autotransfusion for cardiac surgery is transforming medical practices in several European countries. 💡 What makes us unique? i-SEP’s device is the first and only Intra Operative Cell Salvage device capable to wash and recover both red blood cells and platelets during surgery. With same™, we not only reduce reliance on blood donations but also allow patients to receive their own blood cells, significantly minimizing the risk of post-operative complications. 🌍 A global impact We work closely with hospitals in France and internationally to make every surgical procedure safer by optimizing the use of vital resources like blood. Every drop counts, and our mission is to improve healthcare for all through innovative technologies. 🎥 This interview on Télénantes was the perfect opportunity to show how i-SEP is shaping the future of medicine. We strongly believe that innovation can not only improve outcomes but also save lives !

Read more
News 07.24

🌍 World Blood Donor Day: Revolutionizing Blood Resource Management with i-SEP’s same™ Device! 🩸 Today, we highlight a critical issue in Geneva: the chronic shortage of blood donors. But there’s hope thanks to the innovative efforts of HUG – Hôpitaux Universitaires de Genève in rationalizing hemoglobin use. 🔬 A Game-Changing Technology! HUG is testing i-SEP’s same™ device in cardiology operating rooms. This device could potentially halve hemoglobin needs by recovering and purifying blood lost during surgeries, then reinfusing the patient’s own red blood cells and platelets. […]

Read more
123